A 62-year-old man with stage III squamous cell carcinoma of the larynx (T3 N1 M0) is deemed a candidate for concurrent chemoradiation therapy (CCRT). Which chemotherapy agent is the preferred radiosensitizer to be administered weekly during radiation?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.